Literature DB >> 20007911

Prostaglandin I2 promotes recruitment of endothelial progenitor cells and limits vascular remodeling.

Jun-Ichi Kawabe1, Koh-Ichi Yuhki, Motoi Okada, Takayasu Kanno, Atsushi Yamauchi, Naohiko Tashiro, Takaaki Sasaki, Shunsuke Okumura, Naoki Nakagawa, Youko Aburakawa, Naofumi Takehara, Takayuki Fujino, Naoyuki Hasebe, Shuh Narumiya, Fumitaka Ushikubi.   

Abstract

OBJECTIVE: Endothelial progenitor cells (EPCs) play an important role in the self-healing of a vascular injury by participating in the reendothelialization that limits vascular remodeling. We evaluated whether prostaglandin I(2) plays a role in the regulation of the function of EPCs to limit vascular remodeling. METHODS AND
RESULTS: EPCs (Lin(-)cKit(+)Flk-1(+) cells) were isolated from the bone marrow (BM) of wild-type (WT) mice or mice lacking the prostaglandin I(2) receptor IP (IP(-/-) mice). Reverse transcription-polymerase chain reaction analysis showed that EPCs among BM cells specifically express IP. The cellular properties of EPCs, adhesion, migration, and proliferation on fibronectin were significantly attenuated in IP-deficient EPCs compared with WT EPCs. In contrast, IP agonists facilitated these functions in WT EPCs, but not in IP-deficient EPCs. The specific deletion of IP in BM cells, which was performed by transplanting BM cells of IP(-/-) mice to WT mice, accelerated wire injury-mediated neointimal hyperplasia in the femoral artery. Notably, transfused WT EPCs, but not IP-deficient EPCs, were recruited to the injured vessels, participated in reendothelialization, and efficiently rescued the accelerated vascular remodeling.
CONCLUSIONS: These findings clearly indicate that the prostaglandin I(2)-IP system is essential for EPCs to accomplish their function and plays a critical role in the regulation of vascular remodeling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20007911     DOI: 10.1161/ATVBAHA.109.193730

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  18 in total

1.  Engineered endothelial progenitor cells that overexpress prostacyclin protect vascular cells.

Authors:  Qi Liu; Yutao Xi; Toya Terry; Shui-Ping So; Anita Mohite; Jia Zhang; Geru Wu; Xiaobing Liu; Jie Cheng; Ke-He Ruan; James T Willerson; Richard A F Dixon
Journal:  J Cell Physiol       Date:  2012-07       Impact factor: 6.384

Review 2.  Vascular effects of prostacyclin: does activation of PPARδ play a role?

Authors:  Zvonimir S Katusic; Anantha V Santhanam; Tongrong He
Journal:  Trends Pharmacol Sci       Date:  2012-06-23       Impact factor: 14.819

3.  Immortalized multipotent pericytes derived from the vasa vasorum in the injured vasculature. A cellular tool for studies of vascular remodeling and regeneration.

Authors:  Maki Kabara; Jun-ichi Kawabe; Motoki Matsuki; Yoshiki Hira; Akiho Minoshima; Kohei Shimamura; Atsushi Yamauchi; Tatsuya Aonuma; Masato Nishimura; Yukihiro Saito; Naofumi Takehara; Naoyuki Hasebe
Journal:  Lab Invest       Date:  2014-10-20       Impact factor: 5.662

4.  Prostacyclin receptor in tumor endothelial cells promotes angiogenesis in an autocrine manner.

Authors:  Takahiro Osawa; Noritaka Ohga; Yasuhiro Hida; Kazuko Kitayama; Kosuke Akiyama; Yuichiro Onodera; Manabu Fujie; Nobuo Shinohara; Masanobu Shindoh; Katsuya Nonomura; Kyoko Hida
Journal:  Cancer Sci       Date:  2012-04-17       Impact factor: 6.716

Review 5.  Targeting stem cell niches and trafficking for cardiovascular therapy.

Authors:  Nicolle Kränkel; Gaia Spinetti; Silvia Amadesi; Paolo Madeddu
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

6.  Exposure to diesel exhaust upregulates COX-2 expression in ApoE knockout mice.

Authors:  Ni Bai; Erin M Tranfield; Terrance J Kavanagh; Joel D Kaufman; Michael E Rosenfeld; Stephan F van Eeden
Journal:  Inhal Toxicol       Date:  2012-07       Impact factor: 2.724

7.  Regulation of the human prostacyclin receptor gene by the cholesterol-responsive SREBP1.

Authors:  Elizebeth C Turner; B Therese Kinsella
Journal:  J Lipid Res       Date:  2012-09-11       Impact factor: 5.922

8.  Advanced glycation end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cells.

Authors:  Hong Li; Xiaoyun Zhang; Xiumei Guan; Xiaodong Cui; Yuliang Wang; Hairong Chu; Min Cheng
Journal:  Cardiovasc Diabetol       Date:  2012-04-30       Impact factor: 9.951

9.  Interaction of the human prostacyclin receptor with the PDZ adapter protein PDZK1: role in endothelial cell migration and angiogenesis.

Authors:  Elizebeth C Turner; Eamon P Mulvaney; Helen M Reid; B Therese Kinsella
Journal:  Mol Biol Cell       Date:  2011-06-08       Impact factor: 4.138

10.  Sustained-release delivery of prostacyclin analogue enhances bone marrow-cell recruitment and yields functional benefits for acute myocardial infarction in mice.

Authors:  Yukiko Imanishi; Shigeru Miyagawa; Satsuki Fukushima; Kazuhiko Ishimaru; Nagako Sougawa; Atsuhiro Saito; Yoshiki Sakai; Yoshiki Sawa
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.